跳至主要内容
临床试验/NCT00691197
NCT00691197已完成2 期

Safety and Acceptability of Using a Rewetting Drop With Contact Lens Wear

Allergan1 个研究点 分布在 1 个国家目标入组 246 人开始时间: 2008年3月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
发起方
Allergan
入组人数
246
试验地点
1
主要终点
Best Corrected Visual Acuity

研究概览

简要总结

Testing the Safety and Acceptability of Using a Rewetting Drop with Contact Lenses

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Adapted contact lens wearer

排除标准

  • •Monovision lens wearer, ocular or systemic disease, pregnant or planning to become pregnant

研究组 & 干预措施

Carboxymethylcellulose sodium

Active Comparator

Carboxymethylcellulose sodium based rewetting drop

干预措施: Carboxymethylcellulose sodium (Device)

Carboxymethylcellulose sodium and Glycerin

Experimental

Carboxymethylcellulose sodium and Glycerin based rewetting drop

干预措施: Carboxymethylcellulose sodium and Glycerin (Device)

结局指标

主要结局

Best Corrected Visual Acuity

时间窗: Change from Baseline at Day 90

Percentage of Subjects Tabulated by Changes in Line Number at Day 90 from Baseline; Visual Acuity measured by LogMar reported as Snellen equivalents. Better: an increase of 2 lines or more in at least one eye; No Change: a change less than +/- 2 lines in both eyes; Worse: a decrease of 2 lines or more in at least one eye.

次要结局

  • Corneal Staining(Day 90)

研究者

发起方
Allergan
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验

Safety and Acceptability of Using a Rewetting Drop... | 临床试验